141 related articles for article (PubMed ID: 8369577)
1. Management of erythrodermic psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Dermatology; 1993; 187 Suppl 1():30-7. PubMed ID: 8369577
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
[TBL] [Abstract][Full Text] [Related]
4. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
[TBL] [Abstract][Full Text] [Related]
5. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
Meffert H; Bräutigam M; Färber L; Weidinger G
Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
[TBL] [Abstract][Full Text] [Related]
7. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
Peluso AM; Bardazzi F; Tosti A; Varotti C
Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
[TBL] [Abstract][Full Text] [Related]
8. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.
Rongioletti F; Borenstein M; Kirsner R; Kerdel F
J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268
[TBL] [Abstract][Full Text] [Related]
9. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
Salek MS; Finlay AY; Lewis JJ; Sumner MI
Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin therapy in psoriasis: recommendations for treatment. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
Finzi AF; Ippolito F; Panconesi E; Giannotti B; Rebora A
Dermatology; 1993; 187 Suppl 1():38-40. PubMed ID: 8369578
[No Abstract] [Full Text] [Related]
11. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
Ohtsuki M; Nakagawa H; Sugai J; Ozawa A; Ohkido M; Nakayama J; Hanada J; Morimoto Y; Jimbow K; Horikoshi T; Kitahara H; Tamaki K; Urabe K; Hori Y
J Dermatol; 2003 Apr; 30(4):290-8. PubMed ID: 12707465
[TBL] [Abstract][Full Text] [Related]
12. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
[No Abstract] [Full Text] [Related]
13. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
[TBL] [Abstract][Full Text] [Related]
14. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
[No Abstract] [Full Text] [Related]
15. [Treatment of erythrodermic psoriasis with cyclosporin].
Manganoni AM; Giustina A; Zuccato F; Calzavara P; Pasolini G; Braga D; Gavazzoni R
G Ital Dermatol Venereol; 1988 Dec; 123(12):675-6. PubMed ID: 2978160
[No Abstract] [Full Text] [Related]
16. Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Levell NJ; Shuster S; Munro CS; Friedmann PS
Acta Derm Venereol; 1995 Jan; 75(1):65-9. PubMed ID: 7747540
[TBL] [Abstract][Full Text] [Related]
17. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C
Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801
[TBL] [Abstract][Full Text] [Related]
18. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A treatment in severe childhood psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
